Specialty Pharmacy

Top HIV articles of the year on Specialty Pharmacy Times.

Medical marijuana could potentially be used to treat drug addiction and certain mental health conditions.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.

Patients share their personal stories with Specialty Pharmacy Times.

Interaction among probiotics and an intrinsic gut microbiota may influence atopic dermatitis.

Out-of-pocket costs may prevent patients with chronic illnesses from purchasing some Affordable Care Act plans.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.

Top news of the week in oncology and cancer drug development.

Proton pump inhibitors combined with a certain chemotherapy drug may lower the possibility for cancer patients to recover and survive.

Emicizumab prophylaxis reduced the number of bleeds in hemophilia A patients.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Clonidine topical gel fails to achieve desired outcome in reducing pain from diabetic neuropathy.

Scientists have developed a new tool to test current strategies for finding mutant gene cancer drivers.

Regular use of over-the-counter, anti-inflammatory drugs associated with an increased risk of death in patients with cancer.

Administering immunotherapy near the tumor site prevents adverse events associated with the current administration method.

Undisclosed academic and financial conflicts of interest may influence analysis of clinical research.

Investigative drug may improve overall survival and reduce chemotherapy-induced heart damage in children with acute myelogenous leukemia.

Cisplatin used in combination with sodium thiosulfate significantly reduced the incidence of hearing loss in pediatric cancer patients.

Study finds link between aspirin and blood platelets in cancer cells.

Novel immunotherapy shows promise treating patients with leukemia at high-risk of relapse.

Top news of the day from across the health care landscape.

Studies find varying results in incidence of strokes from wet age-related macular degeneration treatment.

Ocrelizumab achieves primary endpoints treating primary progressive multiple sclerosis.

Specialty pharmacies have multiple decisions to make for clinical programs that accompany a contract with a manufacturer.

FDA extends biologics license application review for MS drug ocrelizumab (Ocrevus) to allow for more information on manufacturing process.

Niraparib is an investigational PARP inhibitor currently being evaluated for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers.

Metastasis affects as many as 5% of cancer patients around the world.